Did the COVID-19 Pandemic Affect the Use of Antipsychotics among Nursing Home Residents with ADRD?

The COVID-19 pandemic has disproportionately affected nursing home (NH) residents, whose deaths have accounted for 17 percent of all COVID-related deaths in the US.1,2 The pandemic has created challenges in caring for NH residents, and in particular for those most vulnerable, such as the residents with Alzheimer's disease and related dementias (ADRD), who represent almost half of the NH population.3 The pandemic also impacted NH staff, with more than one million infected by COVID-19,2 and many leaving the industry due to stress, burnout, and increasing workloads.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Tags: Regular Research Article Source Type: research